LifeArc Diagnostics Centre achieves medical device certification within one year of opening
London, UK, 31 August 2018: LifeArc®, one of the UK’s leading medical research charities, proudly announces that its…
LifeArc’s Head of Ventures, Clare Terlouw speaks with @FT Global Pharma Correspondent @hannahkuchler discussing RQ… https://t.co/fqrxEXr3Xf
Innovative diagnostic test for tuberculosis could save millions of lives
Lifearc® the medical research charity, and The University of St Andrews Infection Group today announced a partnership to develop a molecular diagnostic test...
LifeArc appoints Head of Seed Funds
David Holbrook has been appointed to manage our newly created Seed Fund. The £25m fund will invest in innovative early stage therapeutics and biological research aiming to deliver new treatments for patients.
CEO Dave Tapolczay stepping down
Dave Tapolczay, Chief Executive Officer, LifeArc, has announced his intention to step down after 10 years in…
LifeArc announces £5M support for rare disease research
LifeArc®, the medical research charity, today announced its Philanthropic Fund will award £5M in grants to support medical research projects focused on rare diseases.
New partnership in artificial intelligence and machine learning for target discovery announced
New LifeArc®/Milner Therapeutics Institute partnership use machine learning to identify and validate new drug targets in immuno-oncology and respiratory diseases.